FDA Import Refusal 799-9564111-7/10003/1 — AstraZeneca Canada Inc.
The FDA refused shipment 799-9564111-7/10003/1 from AstraZeneca Canada Inc. (Canada) on Nov 18, 2025. The refused product falls under Drugs and Biologics — ANTI-NEOPLASTIC N.E.C.. Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 18, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62IDA99 ANTI-NEOPLASTIC N.E.C.
- Charges
- 118,75